Skip to main content

Table 2 Comparisons of absorbance among groups treated with different concentration rosiglitazones for 12 h (mean ± SD)

From: Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro

groups

wells

Absorbance

control

3

0.25 ± 0.01

ANG II

3

0.51 ± 0.02 *

ANG II + 20 μmol/L Ros

3

0.48 ± 0.02 †

ANG II + 30 μmol/L Ros

3

0.43 ± 0.02 ‡

ANG II + 50 μmol/L Ros

3

0.32 ± 0.01 ‡

  1. *P < 0.01 versus control group; †P < 0.05 versus ANG II group, ‡P < 0.01 versus ANG II group. Comparisons of among different concentration groups P < 0.05 or P < 0.01
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840